Professor, Medicine, University of Miami School of Medicine
Hematology
Dr. Stephen P. Richman, MD
|
|
Give Review
Doctor Stephen P. Richman, MD works in the field of Hematology. He researched medicine at Case Western Reserve University School of Medicine. He over the years received 1 awards: "Super Doctor". Stephen Richman is a published physician as well. He has 22 publications published. The latest was: A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma. Stephen Richman accepts Medicare payments and is registered with Medicare.gov.
Publications
- Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center.
- Pain education for underserved minority Cancer patients: a randomized controlled trial.
- Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control.
- Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized ad...
- The natural history of resectable metastatic melanoma (Stage IVA melanoma).
- Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck Carcinoma.
- Successful control of Systemic Aspergillus niger infections in two patients with acute leukemia.
- Combination chemoimmunotherapy of metastatic breast Cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
- Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effects.
- High-dose cisplatin in patients with advanced Malignancies.
- A phase I trial of dactinomycin intravenous infusion in patients with advanced Malignancies.
- A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokinetics.
- A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinom...
- Comparative study of pamidronate disodium and etidronate disodium in the treatment of Cancer-related hypercalcemia.
- Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced Breast carcinoma.
- Phase II trial of recombinant interferon-alpha with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma.
- Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung Cancer.
- A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced Breast carcinoma.
- High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung Cancer.
- Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast Cancer.
- Minority Cancer patients and their providers: pain management attitudes and practice.
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Texas MD Anderson Cancer Center -
University of Pennsylvania Health System -
Case Western Reserve University School of Medicine
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1538191598 | |
| NPPES Provider LastName | RICHMAN | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 155.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 11.61 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538191598 |
| Last Name Of The Provider | RICHMAN |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
Dr. Pedro U. De La Rosa-Costa, MD |
|
|
Dr. Caio Max S. Rocha-Lima, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Leonard A. Kalman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan B. Leslie, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine F. Welsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Afzal H. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank I. Singleton Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean R. Dauphin, DO |